Single and Multiple Dose Escalation Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered Silymarin (Legalon) in Non-Cirrhotic Subjects With Chronic Hepatitis C or Non-Alcoholic Fatty Liver Disease. 2008 - Reddy, K R; Navarro, V; Afdhal, N; Fried, M
Accessed 25 Aug 2022